Patent US366774A successfully refreshed from Google Patents.
Patent US4339437A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4339437A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-tumor method

Assignee: Research Corp
•
Filing: 1979-07-26
•
Granted: 1982-07-13
•
Expires: 1999-07-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Malignant tumor cells sensitive to platinum coordination compounds in animals are treated by parenterally administering to an affected animal a solution containing a complex compound of platinum in an amount effective to cause regression of the tumor.

Inventors

  • 👤 Barnett Rosenberg
  • 👤 Loretta VanCamp
  • 👤 Thomas Krigas

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 11:16
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/24; A61K33/243

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 81 words
a method of treating animal malignant tumor cells sensitive to a planar dsp 2 platinum(II) coordination compound or an ochtahedral d 2 sp 3 platinum(IV) coordination compound wherein the donor ligands are Cl, Br, CN, NO 3 , ethylene diamine, propylene diamine, pyridine, H 2 O, OH, OS, in animals which comprises parenterally administering to an animal afflicted with said tumor cells a solution containing one of said compounds in an amount sufficient to cause regression of the animal tumor cells.
Claim 2
Independent Claim 81 words
a method of treating animal malignant tumor cells sensitive to a planar dsp 2 platinum(II) coordination compound or an ochtahedral d 2 sp 3 platinum(IV) coordination compound wherein the donor ligands are Cl, Br, CN, NO 3 , ethylene diamine, propylene diamine, pyridine, H 2 O, OH, OS, in animals which comprises parenterally administering to an animal afflicted with said tumor cells a solution containing one of said compounds in an amount sufficient to cause regression of the animal tumor cells.
Claim 3
Dependent Claim 14 words
A method according to claim 1 wherein the solution is administered in multiple doses.
Claim 4
Dependent Claim 15 words
A method according to claim 1 wherein the solution is administered in a single dose.
Claim 5
Dependent Claim 18 words
A method according to claim 1 wherein the compound is administered in a saline or salt-containing buffer solution.
Claim 6
Dependent Claim 12 words
A method according to claim 1 wherein the compound is a chloroplatinumammine.
Claim 7
Dependent Claim 17 words
A method according to claim 1 wherein the compound is cis-Pt(IV)(NH 3 ) 2 Cl 4 .
Claim 8
Dependent Claim 21 words
A method according to claim 1 wherein the compound is Pt(II)(NH 2 CH 2 CH 2 NH 2 )Cl 2 .
Claim 9
Dependent Claim 21 words
A method according to claim 1 wherein the compound is Pt(IV)(NH 2 CH 2 CH 2 NH 2 )Cl 4 .

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-07-12 1986-01-11 1986-07-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-07-12 1990-01-11 1990-07-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-07-12 1994-01-11 1994-07-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag